Chemistry: natural resins or derivatives; peptides or proteins; – Peptides of 3 to 100 amino acid residues – Peptides containing saccharide radicals – e.g. – bleomycins – etc.
Reexamination Certificate
2005-05-03
2005-05-03
Russel, Jeffrey Edwin (Department: 1654)
Chemistry: natural resins or derivatives; peptides or proteins;
Peptides of 3 to 100 amino acid residues
Peptides containing saccharide radicals, e.g., bleomycins, etc.
Reexamination Certificate
active
06887976
ABSTRACT:
Disclosed are glycopeptides that are substituted with one or more substituents each comprising one or more phosphono groups; and pharmaceutical compositions containing such glycopeptide derivatives. The disclosed glycopeptide derivatives are useful as antibacterial agents.
REFERENCES:
patent: 4643987 (1987-02-01), Nagarajan et al.
patent: 4698327 (1987-10-01), Nagarajan et al.
patent: 4727064 (1988-02-01), Pitha
patent: 4983586 (1991-01-01), Bodor
patent: 5024998 (1991-06-01), Bodor
patent: 5591714 (1997-01-01), Nagarajan et al.
patent: 5602112 (1997-02-01), Rubinfeld
patent: 5750509 (1998-05-01), Malabarba et al.
patent: 5840684 (1998-11-01), Cooper et al.
patent: 5916873 (1999-06-01), Cooper et al.
patent: 6323176 (2001-11-01), Jamison et al.
patent: 6392012 (2002-05-01), Judice et al.
patent: 6635618 (2003-10-01), Leadbetter et al.
patent: 0 667 353 (1995-08-01), None
patent: 0 816 378 (1998-01-01), None
patent: 2000-302687 (2000-10-01), None
patent: WO 9412217 (1994-06-01), None
patent: WO 0004044 (2000-01-01), None
patent: WO 0039156 (2000-07-01), None
patent: WO 0054751 (2000-09-01), None
patent: WO 0059528 (2000-10-01), None
patent: WO 0183520 (2001-11-01), None
patent: WO 0197851 (2001-12-01), None
patent: WO 0198326 (2001-12-01), None
patent: WO 0198327 (2001-12-01), None
patent: WO 0198329 (2001-12-01), None
Allen et al., “The Role of Hydrophobic Side Chains as Determinants of Antibacterial Activity of Semisynthetic Glycopeptide Antibiotics”, The Journal of Antibiotics, vol. 50, No. 8, pp 677-684 (1997).
Ge et al., “Vancomycin Derivatives That Inhibit Peptidoglycan Biosynthesis Without Binding D-Ala-D-Ala”, Science, vol. 284, pp 507-511 (1999).
Malabarba et al., “New Semisynthetic Glycopeptides MDL 63,246 and MDL 63,042, and Other Amide Derivatives of Antibiotic A-40, 926 Active against Highly Glycopeptide-resistant VanA Enterococci”, The Journal of Antibiotics, vol. 48, No. 8, pp 869-883 (1995).
Nagarajan et al., “Synthesis and Antibacterial Evaluation of N-Alkyl Vancomycins”, The Journal of Antibiotics, vol. XLII, No. 1, pp 63-72 (1989).
Nicolaou et al., “Chemistry, Biology and Medicine of the Glycopeptide Antibiotics”, Angew, Chem. Int. Ed., vol. 38, pp 2097-2152 (1999).
Pavlov et al., “A New Type of Chemical Modification of Glycopeptides Antibiotics: Aminomethylated Derivatives of Eremomycin and Their Antibacterial Activity”, The Journal of Antibiotics, vol. 50, No. 6, pp 509-513 (1997).
Pavlov et al., “Chemical Modification of Glycopeptide Antibiotics [VC1]”, Russian Journal of Bioorganic Chemistry, vol. 24, No. 9, pp 570-587 (1998).
Pavlov et al., “Mono and Double Modified Teicoplanin Aglycon Derivatives on the Amino Acid No. 7; Structure-activity Relationship”, The Journal of Antibiotics, vol. 51, No. 1, pp 73-78 (1998).
Zhang et al., “A review of recent applications of cyclodextrins for drug discovery”, Expert Opinion on Therapeutic Patents, vol. 9, No. 12, 21 pages (1999).
Leadbetter Michael R.
Linsell Martin S.
Hagenah Jeffrey A.
Russel Jeffrey Edwin
Theravance Inc.
LandOfFree
Glycopeptide phosphonate derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Glycopeptide phosphonate derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Glycopeptide phosphonate derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3413840